Abstract
Fructose-1,6-biphophatase has been regarded as a novel therapeutic target for the treatment of type 2 diabetes mellitus (T2DM). 3D-QSAR and docking studies were performed on a series of [5-(4-amino-1H-benzoimidazol-2-yl)-furan-2-yl]-phosphonic acid derivatives as fructose-1,6-biphophatase inhibitors. The CoMFA and CoMSIA models using thirty-seven molecules in the training set gave r 2cv values of 0.614 and 0.598, r 2 values of 0.950 and 0.928, respectively. The external validation indicated that our CoMFA and CoMSIA models possessed high predictive powers with r 20 values of 0.994 and 0.994, r 2m values of 0.751 and 0.690, respectively. Molecular docking studies revealed that a phosphonic group was essential for binding to the receptor, and some key features were also identified. A set of forty new analogues were designed by utilizing the results revealed in the present study, and were predicted with significantly improved potencies in the developed models. The findings can be quite useful to aid the designing of new fructose-1,6-biphophatase inhibitors with improved biological response.














Similar content being viewed by others
References
Dang Q, Kasibhatla SR, Xiao W, Liu Y, DaRe J, Taplin F, Reddy KR, Scarlato GR, Gibson T, Poelje PD, Potter SC, Erion MD (2010) J Med Chem 53:441–451
Kitas E, Mohr P, Kuhn B, Hebeisen P, Wessel HP, Haap W, Ruf A, Benz J, Joseph C, Huber W, Sanchez RA, Paehler A, Benardeau A, Gubler M, Schott B, Tozzo E (2010) Bioorg Med Chem Lett 20:594–599
Heng S, Harris KM, Kantrowitz ER (2010) Eur J Med Chem 45:1478–1484
Gizak A, Zarzycki M, Rakus D (2009) Biochi Et Bioph Act 1793:871–877
Rudnitskaya A, Huynh K, Torok B, Stieglitz K (2009) J Med Chem 52:878–882
Dang Q, Brown BS, Liu Y, Rydzewsky RM, Robinson ED, Poelje PD, Reddy MR, Erion MD (2009) J Med Chem 52:2280–2898
Dang Q, Kasibhatla SR, Jiang T, Fan K, Liu Y, Taplin F, Schulz W, Cashion DK, Reddy KR, Poelje PD, Fujitake JM, Potter SC, Erion MD (2008) J Med Chem 51:4331–4339
Heng S, Gryncel KR, Kantrowitz ER (2009) Bioorg Med Chem 17:3916–3922
Hebeisen P, Kuhn B, Kohler P, Gubler M, Huber W, Kitas E, Schott B, Benz J, Joseph C, Ruf A (2008) Bioorg Med Chem Lett 18:4708–4712
SYBYL 8.1, Tripos Inc., 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA
Lan P, Huang ZJ, Sun JR, Chen WM (2010) Int J Mol Sci 11:3357–3374
Politi A, Durdagi S, Moutevelis-Minakakis P, Kokotos G, Papadopoulos MG, Mavromoustakos T (2009) Eur J Med Chem 44:3703–3711
Chung JY, Chung HW, Cho SJ, Hah JM, Cho AE (2010) J Comput Aided Mol Des 24:385–397
Liu HY, Liu SS, Qin LT, Mo LY (2009) J Mol Model 15:837–845
Pan X, Tan N, Zeng G, Huang H, Yan H (2010) Eur J Med Chem 45:667–681
Lu XY, Chen YD, You QD (2010) Chem Biol Drug Des 75:195–203
Murumkar PR, Zambre VP, Yadav MR (2010) J Comput Aided Mol Des 24:143–156
Tsukada T, Takahashi M, Takemoto T, Kanno O, Yamane T, Kawamura S, Nishi T (2010) Bioorg Med Chem 20:1004–1007
Pasha FA, Muddassar M, Srivastava AK, Cho SJ (2010) J Mol Model 16:263–277
Durdagi S, Mavromoustakos T, Papadopoulos MG (2008) Bioorg Med Chem Lett 18:6283–6289
Golbraikh A, Tropsha A (2002) J Mol Graph Model 20:269–276
Roy PP, Roy K (2008) QSAR Comb Sci 27:302–313
Lu P, Wei X, Zhang R (2010) Eur J Med Chem 45:3413–3419
Basu A, Jasu K, Jayaprakash V, Mishra N, Ojha P, Bhattacharya S (2009) Eur J Med Chem 44:2400–2407
Acknowledgments
This research work is supported by “the Fundamental Research Funds for the Central Universities” (No. 21610405), China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lan, P., Xie, MQ., Yao, YM. et al. 3D-QSAR studies and molecular docking on [5-(4-amino-1H-benzoimidazol-2-yl)-furan-2-yl]-phosphonic acid derivatives as fructose-1,6-biphophatase inhibitors. J Comput Aided Mol Des 24, 993–1008 (2010). https://doi.org/10.1007/s10822-010-9391-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-010-9391-z